Trading Window closure

Sun Pharmaceutical Industries Limited SUN HOUSE, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, India Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343 Website: www.sunpharma.com Email: secretarial@sunpharma.com CIN: L24230GJ1993PLC019050 25 September 2026 National Stock Exchange of India Limited BSE Limited Scrip Symbol: SUNPHARMA Scrip Code: 524715 Trading Window Closure Pursuant to the Company’s Code of Conduct for Prohibition of Insider Trading, the Trading Window for dealing in Company’s shares shall remain closed during the period starting from 01 October 2026, till 48 hours after the declaration of Unaudited Financial Results for the quarter and half year ended 30 September 2026. The date of the Board Meeting to consider and approve the Unaudited Financial Results for the quarter and half year ended 30 September 2026 shall be communicated in due course. For Sun Pharmaceutical Industries Limited (Anoop Deshpande) Company Secretary and Compliance Officer ICSI Membership No.: A23983 Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA Reaching People. Touching Lives